Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes - Concepedia

Concepedia

Publication | Closed Access

Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes

11

Citations

36

References

2021

Year

Elaine M. Walsh, Neha Mangini, John H. Fetting, Deborah K. Armstrong, Isaac S. Chan, Roisín M. Connolly, Katie Fiallos, Jennifer Lehman, Raquel Nunes, Dana Petry,

Clinical Breast Cancer

Olaparib UseBreast OncologySomatic VariantMedicinePathologyCancer GenomicsBreast CancerCancer TreatmentOncologyCell Biology

References

	Year	Citations

Page 1

Page 1